Related Experiment Video
Updated: Dec 21, 2025
09:08
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
6.1K
Recent advances in understanding and managing cutaneous T-cell lymphomas
Patrick M Brunner1, Constanze Jonak1, Robert Knobler1
1Department of Dermatology, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, 1090, Austria.
F1000Research
|May 19, 2020
Summary
Cutaneous T-cell lymphomas (CTCLs) are skin cancers with poor survival in advanced stages. Current treatments are palliative, highlighting the need for better diagnostics and therapies for this challenging disease.
Area of Science:
- Oncology
- Dermatology
- Immunology
Background:
- Cutaneous T-cell lymphomas (CTCLs) are a group of skin cancers, with mycosis fungoides being the most common type.
- Early-stage CTCL often progresses, leading to poor prognoses and reduced survival rates in advanced stages (IIB-IVB).
- Current treatments for CTCL are palliative, focusing on quality of life as there is no definitive cure besides stem cell transplantation.
Purpose of the Study:
- To review the pathogenesis of CTCL, including immune system changes in progressive disease.
- To discuss diagnostic challenges in early-stage CTCL due to a lack of reliable markers.
- To explore established and emerging treatment options, including immunotherapy and targeted therapies.
Main Methods:
- Literature review of current understanding of CTCL pathogenesis.
- Analysis of diagnostic challenges in early-stage disease.
- Discussion of existing and potential therapeutic strategies.
Main Results:
- CTCL pathogenesis involves immune system shifts as the disease progresses.
- Early diagnosis of CTCL is hindered by the absence of specific diagnostic markers.
- Established treatments are palliative, necessitating research into novel therapeutic approaches.
Conclusions:
- Understanding CTCL pathogenesis and immune changes is crucial.
- Improved diagnostic tools are needed for early detection and intervention.
- Further research into immunotherapies and targeted agents is essential for advancing CTCL treatment.
Related Concept Videos
01:30Skin Cancer
5.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.6K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:27Cytotoxic T Cells-mediated Immune Response
6.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
01:23Skin Diseases and Disorders
5.0K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.0K
01:22T Cell Activation and Clonal Selection
14.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.4K
02:57Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K